Gemma Saravanos

1.1k total citations
18 papers, 411 citations indexed

About

Gemma Saravanos is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gemma Saravanos has authored 18 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 6 papers in Infectious Diseases and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gemma Saravanos's work include Respiratory viral infections research (12 papers), Influenza Virus Research Studies (4 papers) and Pneumonia and Respiratory Infections (4 papers). Gemma Saravanos is often cited by papers focused on Respiratory viral infections research (12 papers), Influenza Virus Research Studies (4 papers) and Pneumonia and Respiratory Infections (4 papers). Gemma Saravanos collaborates with scholars based in Australia, India and United Kingdom. Gemma Saravanos's co-authors include Philip N Britton, Kristine Macartney, Raghu Lingam, Nicholas Wood, Alison Kesson, Nan Hu, Nusrat Homaira, Nicholas Wood, Tom Snelling and Cheryl McCullagh and has published in prestigious journals such as PLoS ONE, PEDIATRICS and The Journal of Infectious Diseases.

In The Last Decade

Gemma Saravanos

17 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gemma Saravanos Australia 9 353 179 136 65 25 18 411
Frederic Reicherz Canada 8 252 0.7× 131 0.7× 107 0.8× 38 0.6× 17 0.7× 13 302
Ariel O Mace Australia 4 372 1.1× 163 0.9× 150 1.1× 70 1.1× 35 1.4× 5 452
Angela J. Peck United States 6 289 0.8× 121 0.7× 178 1.3× 38 0.6× 25 1.0× 7 434
Valtýr Thors Iceland 10 262 0.7× 94 0.5× 95 0.7× 39 0.6× 19 0.8× 36 367
Linny Kimly Phuong Australia 9 167 0.5× 73 0.4× 107 0.8× 97 1.5× 21 0.8× 19 297
Kevin T. Shiley United States 9 250 0.7× 97 0.5× 126 0.9× 45 0.7× 10 0.4× 13 386
Frances L. Vaughn United States 6 363 1.0× 103 0.6× 185 1.4× 15 0.2× 65 2.6× 6 608
Marie‐Noëlle Billard Canada 8 317 0.9× 136 0.8× 95 0.7× 54 0.8× 22 0.9× 12 354
Marjut Haapanen Finland 8 152 0.4× 63 0.4× 59 0.4× 64 1.0× 21 0.8× 17 254
J.E. Guerrero Spain 11 270 0.8× 148 0.8× 174 1.3× 28 0.4× 68 2.7× 26 483

Countries citing papers authored by Gemma Saravanos

Since Specialization
Citations

This map shows the geographic impact of Gemma Saravanos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma Saravanos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma Saravanos more than expected).

Fields of papers citing papers by Gemma Saravanos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gemma Saravanos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma Saravanos. The network helps show where Gemma Saravanos may publish in the future.

Co-authorship network of co-authors of Gemma Saravanos

This figure shows the co-authorship network connecting the top 25 collaborators of Gemma Saravanos. A scholar is included among the top collaborators of Gemma Saravanos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gemma Saravanos. Gemma Saravanos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Saravanos, Gemma, Alison Kesson, Kin‐Chuen Leung, et al.. (2025). Respiratory virus detections in children presenting to an Australian paediatric referral hospital pre-COVID-19 pandemic, January 2014 to December 2019. PLoS ONE. 20(1). e0313504–e0313504. 2 indexed citations
3.
Chan, Mei, Nan Hu, Brendan McMullan, et al.. (2024). Clinical Characteristics and In-hospital Outcomes Associated With Respiratory Syncytial Virus vs Other Viral Acute Lower Respiratory Infections in Hospitalized Children Younger Than 2 Years. The Journal of Infectious Diseases. 231(5). 1309–1317. 1 indexed citations
4.
Saravanos, Gemma, et al.. (2024). Planetary health and person‐centred healthcare practice. Journal of Advanced Nursing. 81(1). 537–540. 3 indexed citations
5.
Chan, Mei, Nan Hu, Brendan McMullan, et al.. (2024). Risk Factors and Clinical Prognosis Associated With RSV-ALRI Intensive Care Unit Admission in Children <2 Years of Age: A Multicenter Study. The Pediatric Infectious Disease Journal. 43(6). 511–517. 3 indexed citations
6.
Saravanos, Gemma, et al.. (2023). Unintended impacts of COVID-19 on the epidemiology and burden of paediatric respiratory infections. Paediatric Respiratory Reviews. 53. 3–13. 27 indexed citations
7.
Chan, Mei, Md Saiful Islam, Gemma Saravanos, et al.. (2023). Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high‐risk infants. Pediatric Pulmonology. 58(4). 1210–1220. 4 indexed citations
8.
Williams, Phoebe, Archana Koirala, Gemma Saravanos, et al.. (2022). COVID ‐19 in New South Wales children during 2021: severity and clinical spectrum. The Medical Journal of Australia. 217(6). 303–310. 14 indexed citations
9.
Saravanos, Gemma, Nan Hu, Nusrat Homaira, et al.. (2022). RSV Epidemiology in Australia Before and During COVID-19. PEDIATRICS. 149(2). 84 indexed citations
10.
Saravanos, Gemma, Catherine King, Lucy Deng, et al.. (2021). Respiratory Syncytial Virus–Associated Neurologic Complications in Children: A Systematic Review and Aggregated Case Series. The Journal of Pediatrics. 239. 39–49.e9. 26 indexed citations
11.
Saravanos, Gemma, et al.. (2021). Respiratory syncytial virus subtype circulation and associated disease severity at an Australian paediatric referral hospital, 2014–2018. Journal of Paediatrics and Child Health. 57(8). 1190–1195. 13 indexed citations
12.
Britton, Philip N, Nan Hu, Gemma Saravanos, et al.. (2020). COVID-19 public health measures and respiratory syncytial virus. The Lancet Child & Adolescent Health. 4(11). e42–e43. 144 indexed citations
13.
Saravanos, Gemma, et al.. (2020). A high proportion of interseasonal childhood influenza cases in 2019 were travel related. Public Health Research & Practice. 30(2). 3 indexed citations
14.
Quinn, Helen, Gemma Saravanos, Samantha Carlson, et al.. (2020). Paediatric Active Enhanced Disease Surveillance (PAEDS) 2017 and 2018: Prospective hospital-based surveillance for serious paediatric conditions. Communicable Diseases Intelligence. 44. 10 indexed citations
15.
Quinn, Helen, Gemma Saravanos, Alissa McMinn, et al.. (2019). Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2016: Prospective hospital-based surveillance for serious paediatric conditions. Communicable Diseases Intelligence. 43. 15 indexed citations
16.
Saravanos, Gemma, Meru Sheel, Nusrat Homaira, et al.. (2019). Respiratory syncytial virus‐associated hospitalisations in Australia, 2006–2015. The Medical Journal of Australia. 210(10). 447–453. 48 indexed citations
17.
Roberts, Daniel P., et al.. (2018). Evaluation of national guidelines for bronchiolitis: AGREEments and controversies. Journal of Paediatrics and Child Health. 55(1). 25–31. 8 indexed citations
18.
Phillips, Anastasia, Frank Beard, Kristine Macartney, et al.. (2018). Vaccine‐preventable child deaths in New South Wales from 2005 to 2014: How much is preventable?. Journal of Paediatrics and Child Health. 54(4). 356–364. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026